TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
EBS

Emergent Biosolutions Inc

Healthcare · Drug Manufacturers - Specialty & Generic

6.80$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Emergent Biosolutions Inc (EBS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,117 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EBS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
932 970 952 970 1,024 1,070 1,068 1,139 1,174 2,229 2,154 2,321 2,334 2,327 2,279 2,466 2,616 2,883 2,900 2,915 2,868 2,959 2,780 2,735 2,909 3,167 2,950 2,179 1,893 1,835 1,804 1,514 1,478 1,397 1,426 1,417 1,461 1,319 1,320 1,117
480 510 489 510 556 485 477 541 563 621 529 693 700 686 627 755 959 1,196 1,140 1,122 1,074 1,272 1,100 1,084 1,085 1,211 1,194 747 711 680 682 655 661 599 707 720 787 663 638 666
299 272 270 316 341 178 164 190 339 112 137 177 139 168 182 269 415 621 548 448 404 576 436 358 241 643 430 89 88 112 79 70 150 106 149 271 246 205 160 140
299 272 270 316 341 178 164 190 339 112 137 177 139 168 182 269 415 621 548 448 404 576 436 358 241 643 430 89 88 112 79 70 150 106 149 271 246 205 160 140
81 148 135 109 129 146 129 189 77 263 122 218 281 275 173 259 196 231 184 262 255 275 182 175 191 158 156 290 217 191 234 196 121 155 204 80 150 84 122 190
81 74 71 71 69 143 155 139 126 206 211 232 230 223 248 236 270 307 407 386 365 351 401 426 546 352 368 354 354 329 333 318 323 312 314 339 356 343 328 304
363 376 381 380 386 407 411 419 435 510 513 521 529 542 549 580 607 644 693 773 769 800 808 798 807 818 717 396 413 – – – 291 282 228 224 217 216 – –
41 41 41 41 41 49 49 49 49 260 268 268 269 267 266 266 267 267 267 267 267 225 225 225 225 218 218 218 218 0.0 – – 0.0 – – – – – – –
35 34 32 31 29 120 116 112 108 812 798 783 769 742 737 722 678 663 648 633 619 605 591 577 723 729 609 593 583 567 550 534 518 502 485 469 453 437 470 262
384 374 341 350 360 158 187 201 207 1,219 1,166 1,332 1,299 1,239 1,204 1,267 1,365 1,436 1,377 1,372 1,345 1,340 1,205 1,222 1,459 1,784 1,747 1,223 1,196 1,186 1,140 1,127 969 914 873 881 879 796 797 775
110 106 68 73 75 100 87 97 102 200 248 301 275 216 207 294 299 385 370 378 365 374 249 277 268 1,230 1,216 693 664 651 630 620 230 162 112 127 137 132 149 123
20 20 28 26 38 43 31 43 49 10 10 10 10 16 31 34 41 45 31 35 37 32 37 32 27 957 954 459 417 417 463 418 3.5 2.7 0.0 1.8 0.0 0.0 – –
46 35 27 30 30 42 46 42 39 81 79 125 91 95 84 85 103 136 142 152 135 129 107 106 104 104 124 108 113 112 100 96 82 61 58 64 57 56 40 50
248 248 248 249 249 13 13 13 13 785 732 830 813 798 763 758 849 841 833 825 817 809 802 794 1,032 449 448 448 448 447 447 447 662 664 666 668 663 572 574 582
548 596 610 621 664 912 881 938 967 1,011 988 989 1,035 1,089 1,075 1,199 1,252 1,447 1,523 1,544 1,523 1,619 1,575 1,513 1,449 1,383 1,203 956 697 649 664 386 508 483 553 536 583 523 523 341
215 254 265 270 303 337 300 350 371 367 342 332 375 422 409 502 542 727 797 801 769 958 954 898 822 734 551 290 28 -22 -13 -296 -181 -212 -144 -156 -105 -160 -153 -333
49 50 50 50 50 51 50 51 51 51 51 52 52 53 52 54 54 54 55 54 54 54 51 50 50 50 50 51 52 52 52 53 56 54 57 54 57 52 57 52

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?